Supplier News
Reprints Desk Launches Google Reader Alternative
March 21, 2013 2:09 pm | News | CommentsReprints Desk Inc. has launched its really simple syndication (RSS) feed import functionality inside Bibliogo. The new functionality was created specifically to accommodate the needs of professionals who are seeking an alternative to Google Reader feed reader after the announcement that Google will be powering down the service in July 2013.
Qiagen, Lilly Expand Diagnostic Partnership
February 13, 2013 5:34 pm | News | CommentsDiagnostic products maker Qiagen NV will work with Eli Lilly to develop new tests that could identify patients who could be helped by Lilly's drugs. The companies did not disclose terms of the new collaboration, but described it as a "broad" partnership that will cover "all therapeutic areas."
Pfizer, Agilent Partner on Companion Diagnostics
February 13, 2013 11:13 am | News | CommentsAgilent Technologies Inc. will work with Pfizer Inc. to develop diagnostic tests. Agilent announced its Dako division will help develop companion diagnostic tests, which are designed to help physicians decide how to treat patients by showing which treatments they might respond to.
Agilent, Pfizer Form Diagnostic Partnership
February 12, 2013 2:31 pm | by The Associated Press | News | CommentsAgilent Technologies Inc. announced that it will work with Pfizer Inc., the biggest drug company in the world, to develop companion diagnostic tests, which are designed to help physicians decide how to treat patients by showing which treatments they might respond to.
Rockland Acquires TrueBlot Line
December 18, 2012 4:59 pm | News | CommentsRockland Immunochemicals Inc. announced the acquisition of the TrueBlot IP/Western blot product line from eBioscience, Inc., an Affymetrix company. Western blotting, a critical assay that is a widely accepted analytical technique in both scientific research and medical diagnosis, is used to determine expression and quantitate target proteins in biological samples.
Beatica Discovering Compounds for Janssen
December 14, 2012 4:40 pm | News | CommentsBeactica has added a project under its ongoing research services agreement with Janssen Research & Development. Beactica will use its proprietary drug discovery platform Sprint to identify novel allosteric modulators targeting undisclosed central nervous system proteins of therapeutic interest to Janssen.
Capsugel Opens New QC Laboratory
December 14, 2012 9:08 am | News | CommentsCapsugel announced it has doubled its laboratory capacity with the opening of a quality control laboratory in Greenwood, S.C. The laboratory serves as a global resource to its extensive network of manufacturing sites and R&D laboratories located in Boston, Strasbourg, and Colmar.
Rhenovia Files Transdermal Patents
December 12, 2012 4:51 pm | News | CommentsRhenovia Pharma has filed two patent applications for RHEpatch, Rhenovia’s electronic transdermal patch for people suffering from chronic diseases. RHEpatch was originally designed to optimize the delivery of drugs to patients suffering from diseases of the nervous system.
WiCell Expands Microarray Offerings
December 11, 2012 3:55 pm | News | CommentsWiCell, a leader in the cytogenetic testing of mouse and human embryonic stem cells and induced pluripotent stem cells, is offering comparative genomic hybridization plus single nucleotide polymorphism microarray analysis using the Agilent SurePrint G3 Human Genome CGH+SNP Microarray.
Agilent, SRI Sign Licensing Deal
December 10, 2012 5:00 pm | News | CommentsAgilent Technologies Inc. and SRI International announced they have signed a licensing agreement to offer laboratory research customers a package that combines Agilent’s latest release of GeneSpring GX, GeneSpring NGS, Mass Profiler Professional and Pathway Architect version 12.5 with SRI International’s complete BioCyc Pathway Database Collection.
Cenduit Offers Clinical Trial Supply Simulation, Forecasting Service
December 4, 2012 9:13 am | News | CommentsSFDA Approves careHPV Test
November 29, 2012 9:20 am | News | CommentsQiagen N.V. announces that China’s State Food and Drug Administration has approved the company’s careHPV Test and instrument platform. The careHPV Test is the first molecular diagnostic to screen for high risk human papillomavirus designed for low-resource clinical settings, such as areas lacking electricity, water, or modern laboratory infrastructure.
Results of Stribild Study Announced
November 28, 2012 10:59 am | News | CommentsGilead Sciences has announced two-year results from two pivotal Phase 3 studies (Studies 102 and 103) evaluating the company's single tablet HIV regimen, Stribild (elvitegravir 150 mg/cobicistat 150 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg), among treatment-naïve patients with HIV-1 infection.
U.S. Pharmacopeia Hosts Workshop on Bioassays
November 27, 2012 10:20 am | News | CommentsThe development, monitoring, validation and revalidation of bioassays to measure the potency of biologic drugs are critical. On Dec. 4-5, 2012, the United States Pharmacopeial Convention (USP) will host the Fifth Bioassay Workshop at its headquarters in Rockville, Md., to discuss these topics.
Agilent Opens New Manufacturing Facility
November 21, 2012 10:06 am | News | CommentsAgilent Technologies Inc. has opened a new X-ray diffraction manufacturing facility in Wrocław, Poland. The state-of-the-art facility gives Agilent significantly greater manufacturing capacity and enhanced R&D capabilities compared with the company’s old facility.
BioCat Sign Agreement with ALPCO
November 20, 2012 4:30 pm | News | CommentsBioCat announces the signing of an exclusive distribution agreement with ALPCO Diagnostics. The agreement names BioCat as the exclusive distributor for ALPCO products in Germany. ALPCO Diagnostics is know for their insulin ELISA kits and other market-leading metabolism assays.
PPD Signs Trial Design Deal
November 15, 2012 2:59 pm | News | CommentsPPD has signed an agreement to use Tessella and Berry Consultants' FACTS software to create a more flexible, intuitive approach for trial design. The software expands PPD's adaptive design capabilities by giving biopharmaceutical companies greater ability to use simulations to investigate study design options.
Plexpress Extends Admescope Deal
November 14, 2012 3:53 pm | News | CommentsPlexpress has announced plans to extend its collaboration with Admescope. The Tracpack induction screening service is optimized for screening high priority drug candidates, producing all the data required to meet Food and Drug Administration regulations.
CEVEC, CSS Sign License Agreement
November 13, 2012 4:37 pm | News | CommentsCEVEC Pharmaceuticals and CCS Cell Culture Service GmbH announced the signing of a strategic license agreement. The license will enable CCS to offer its customers transiently transfected CAP-T cells for cell based assay and protein production applications.
Fujifilm, Piramal Work on ADCs
November 12, 2012 3:43 pm | News | CommentsFujifilm Diosynth Biotechnologies has announced it has entered into a strategic alliance with Piramal Healthcare UK Ltd, whereby the two parties will offer the contract development and manufacture of antibody drug conjugates, a growing niche in the development of biopharmaceuticals.
Crown, Horizon Showcase X-MAN Cell Lines
November 9, 2012 2:27 pm | News | CommentsCrown Bioscience Inc. and Horizon Discovery Ltd. will highlight the availability of X-MAN cell lines for in vitro and in vivo drug discovery model validation. Human disease models are crucial for generating patient-relevant targets and facilitating the development of novel oncology targets.
IO, Sage-N Launch IDA
November 8, 2012 3:20 pm | News | CommentsIO Informatics, the leader in semantic data integration and knowledge management for life sciences and healthcare, announced it has launched its Sentient iDA in cooperation with Sage-N Research, Inc., the inventor of Integrated Data Appliance (iDA) systems.
Agilent, Roche Sign Service Agreement
November 7, 2012 3:20 pm | News | CommentsAgilent Technologies Inc. and Roche announced the signing of an exclusive agreement to provide continued service to NimbleGen microarray customers as Roche phases out its NimbleGen array production and services. Researchers use NimbleGen microarrays for many applications.
